FDA Inspection 1108752 — Padagis US LLC
The FDA completed an inspection of Padagis US LLC on Oct 23, 2019 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 23, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Minneapolis, MN (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)